{"id":20847,"date":"2019-01-08T09:32:23","date_gmt":"2019-01-08T01:32:23","guid":{"rendered":"https:\/\/www.kuaiqikan.com\/?p=20847"},"modified":"2019-01-08T09:32:23","modified_gmt":"2019-01-08T01:32:23","slug":"ju-ge-li-zi-gao-su-ni-sci-wen-zhang-ru-he-gao-xiao-xuan-ti","status":"publish","type":"post","link":"https:\/\/www.kuaiqikan.com\/ju-ge-li-zi-gao-su-ni-sci-wen-zhang-ru-he-gao-xiao-xuan-ti\/","title":{"rendered":"\u4e3e\u4e2a\u6817\u5b50\uff1f\u544a\u8bc9\u4f60SCI\u6587\u7ae0\u5982\u4f55\u9ad8\u6548\u9009\u9898"},"content":{"rendered":"

 <\/p>\n

\n
\n
\u00a0 \u00a0 \u00a0 \u00a0\u53ea\u8981\u786e\u7acb\u4e00\u4e2a\u597d\u7684\u9009\u9898\uff0c\u624d\u6709\u80fd\u591f\u5199\u51fa\u4e00\u7bc7\u597d\u8bba\u6587\u3002\u666e\u901a\u610f\u4e49\u4e0a\uff0c\u9009\u9898\u662f\u6307\u8981\u9009\u62e9\u4e00\u4e2a\u6070\u5f53\u7684\u8bba\u9898\u3001\u63d0\u51fa\u6709\u610f\u4e49\u7684\u8bba\u70b9\uff0c\u5e76\u9009\u62e9\u5408\u9002\u7684\u5199\u4f5c\u65b9\u5f0f\u3002\u76f8\u53cd\uff0c\u8bba\u70b9\u4e0d\u65b0\u6216\u6ca1\u6709\u4ef7\u503c\uff0c\u5373\u4fbf\u8a00\u8bed\u534e\u7f8e\u3001\u8868\u8fbe\u8fdf\u6ede\u3001\u6784\u9020\u6e05\u695a\uff0c\u4e5f\u4e0d\u80fd\u5199\u51fa\u597d\u7684\u8bba\u6587\u3002\u4eceSCI\u6742\u5fd7\u7684\u89d2\u5ea6\uff0c\u5728\u7f16\u8f91\u521d\u5ba1\u7a3f\u4ef6\u65f6\uff0c\u9996\u5148\u5c31\u662f\u770b\u9009\u9898\uff0c\u8fd9\u662f\u8bc4\u5224\u4e00\u7bc7\u8bba\u6587\u80fd\u5426\u91c7\u7528\u7684\u6839\u672c\u89c4\u8303\u3002<\/p>\n<\/section>\n<\/section>\n<\/section>\n
\n
\n
\u3000\u3000\u4e00. \u5982\u4f55\u9009\u9898<\/strong><\/p>\n

\u597d\u9898\u662f\u53ef\u8bba\u4e4b\u9898\u52a0\u6709\u4ef7\u4e4b\u8bf4\u3002\u9009\u9898\u7684\u597d\u574f\u6b21\u8981\u7684\u672c\u6e90\u5728\u4e8e\u80fd\u5426\u53d1\u73b0\u6210\u7ee9\uff0c\u53ea\u8981\u53d1\u73b0\u4e86\u6210\u7ee9\u624d\u5e72\u627e\u5230\u7814\u8ba8\u7684\u76ee\u7684\u4ee5\u53ca\u4e3a\u4f55\u8981\u5904\u7406\u8fd9\u4e2a\u6210\u7ee9\u3002\u6709\u5f88\u591a\u4eba\u56f0\u60d1\u4e8e\u65e0\u9898\u53ef\u627e\u3001\u65e0\u9898\u53ef\u9009\uff0c\u5176\u5b9e\u8fd9\u91cc\u6b21\u8981\u5c31\u662f\u77ed\u5c11\u5bdf\u770b\u548c\u77ed\u5c11\u53d1\u73b0\u3002\u8bba\u9898\u5e94\u662f\u53ef\u8bba\u4e4b\u9898\uff0c\u4f46\u662f\u8bba\u9898\u89e6\u53ca\u7684\u8303\u56f4\u4e00\u5b9a\u8981\u9002\u4e2d\u3002\u8bba\u9898\u4e0d\u5b9c\u8fc7\u5c0f\uff0c\u9053\u7406\u5341\u5206\u7c97\u6d45\u6216\u8bb8\u4e0d\u8a00\u800c\u55bb\u7684\u6210\u7ee9\uff0c\u96be\u4ee5\u5c55\u5f00\u9610\u8ff0\uff0c\u82e5\u5f3a\u4f5c\u8bba\u6587\uff0c\u5c31\u6210\u7acb\u501f\u9898\u53d1\u6325\u4e86\u3002\u8bba\u9898\u4e5f\u4e0d\u8981\u8fc7\u5927\uff0c\u7531\u4e8e\u5927\u9898\u90fd\u4f1a\u89e6\u53ca\u5f88\u591a\u5185\u5bb9\uff0c\u5f88\u96be\u7528\u4e00\u7bc7\u8bba\u6587\u9610\u8ff0\u6e05\u695a\uff0c\u5047\u5982\u9053\u7406\u96be\u514d\u8bf4\u5f97\u7b3c\u7edf\uff0c\u4f1a\u8ba9\u8bfb\u8005\u611f\u5230\u95f4\u9694\u5f88\u8fdc\u3001\u65e0\u6cd5\u4e86\u89e3\u3002<\/p>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\u3000\u3000\u4e8c. \u4ece\u75c5\u4f8b\u62a5\u544a\u9009\u9898<\/strong><\/p>\n

\u75c5\u4f8b\u62a5\u544a\u662f\u5bf9\u5355\u4e2a\u6216\u591a\u6570\u7a00\u6709\u75c5\u4f8b\u7684\u4e34\u5e8a\u62a5\u9053\uff0c\u8fd9\u662f\u4e34\u5e8a\u533b\u5b66\u7814\u8ba8\u751f\u64b0\u5199 SCI \u8bba\u6587\u7684\u6377\u5f84\uff0c\u4e5f\u662f\u5f88\u68d2\u7684\u57f9\u80b2 SCI \u8bba\u6587\u5199\u4f5c\u7684\u8bad\u7ec3\u529e\u6cd5\u3002\u6211\u4eec\u5728\u4e34\u5e8a\u4efb\u52a1\u4e2d\u5fc5\u9700\u64c5\u957f\u53d1\u73b0\u548c\u603b\u7ed3\uff0c\u624d\u5e72\u5199\u51fa\u9ad8\u7a0b\u5ea6\u7684\u3001\u6709\u81ea\u521b\u4ef7\u503c\u7684\u75c5\u4f8b\u62a5\u544a\uff0c\u5728\u6b64\u4e3e\u4f8b\u9610\u660e\u3002<\/p>\n

\u4f8b\u4e00\uff0c\u6838\u7d20\u533b\u6cbb\u662f\u4e34\u5e8a\u6838\u533b\u5b66\u7684\u91cd\u8981\u5185\u5bb9\uff0c\u5728\u5206\u5316\u578b\u7532\u72b6\u817a\u764c\u60a3\u8005\u624b\u672f\u540e\u7898-131\u533b\u6cbb\u7684\u8fdb\u7a0b\u4e2d\uff0c\u82e5\u5448\u73b0\u5047\u9633\u6027\u75c5\u7076\u4f1a\u5206\u660e\u6405\u6270\u6838\u533b\u5b66\u533b\u751f\u5bf9\u7898-131\u533b\u6cbb\u6548\u679c\u7684\u5224\u522b\uff0c\u5728\u6211\u79d1\u7684\u4e34\u5e8a\u4efb\u52a1\u4e2d\uff0c\u6211\u4eec\u53d1\u73b0\u4e00\u4f8b\u7532\u72b6\u820c\u7ba1\u56ca\u80bf\u7684\u60a3\u8005\uff0c\u8fd9\u662f\u4e00\u4f4d44\u5c81\u7684\u7532\u72b6\u817a\u4e73\u5934\u72b6\u764c\u7684\u7537\u6027\u60a3\u8005\uff0c\u672f\u540e\u4e00\u5171\u7ed9\u4e88\u4e86\u4e09\u6b21\u7898-131\u533b\u6cbb\uff0c\u6211\u4eec\u53d1\u5982\u4eca\u5176\u9888\u524d\u6709\u4e00\u4e2a\u5206\u660e\u7684\u9633\u6027\u75c5\u7076\uff0c\u5728\u533b\u6cbb\u4e2d\u8be5\u75c5\u7076\u7684\u5f62\u72b6\u548c\u6d53\u96c6\u6c34\u5e73\u4e00\u76f4\u4e0d\u53d8\uff0c\u7ecf\u8fc7\u8d85\u58f0\u3001CT \u548c MR\uff0c\u6700\u7ec8\u660e\u767d\u662f\u7532\u72b6\u820c\u7ba1\u56ca\u80bf\u5f62\u6210\u7684\u5047\u9633\u6027\uff0c\u6b64\u60a3\u8005\u533b\u6cbb\u540e\u7684\u8bc4\u4ef7\u7232\u4e34\u5e8a\u6cbb\u6108\uff0c\u81ea\u5df1\u6307\u70b9\u7855\u58eb\u7814\u8ba8\u751f\u5c06\u6b64\u6587\u5ba3\u5e03\u4e8e 3.5 \u5206\u7684\u6742\u5fd7 Clinical Nuclear Medicine\u3002<\/p>\n

\u4f8b\u4e8c\uff0c\u5168\u8eab\u9aa8\u663e\u50cf\u662f\u6838\u533b\u5b66\u663e\u50cf\u4e2d\u7684\u60ef\u4f8b\u9879\u76ee\uff0c\u5168\u8eab\u9aa8\u663e\u50cf\u4e2d\u5448\u73b0\u5355\u4e2a\u808b\u9aa8\u9633\u6027\u75c5\u7076\u7684\u72b6\u51b5\u5076\u7136\u4f1a\u9047\u5230\uff0c\u6211\u4eec\u7684\u56e2\u961f\u5bf9\u9047\u5230\u7684\u6b64\u7c7b\u72b6\u51b5\u6ca1\u6709\u653e\u8fc7\uff0c\u6211\u5e26\u9886\u7814\u8ba8\u751f\u5bf9\u53d1\u73b0\u7684\u4e24\u4e2a\u75c5\u4f8b\u8ffd\u8e2a\u7a76\u7adf(\u67e5\u627e\u75c5\u5386\u3001\u641c\u96c6\u5f71\u50cf\u5b66\u6750\u6599\u548c\u786e\u8ba4\u75c5\u7406\u5b66\u8bca\u65ad)\uff0c\u660e\u767d\u4e86\u808b\u9aa8\u6d77\u7ef5\u72b6\u8840\u7ba1\u7624\u548c\u7ea4\u7ef4\u7ec4\u7ec7\u7ec6\u80de\u7624\u7684\u6700\u7ec8\u8bca\u65ad\uff0c\u6210\u529f\u53c8\u5728 Clinical Nuclear Medicine \u6742\u5fd7\u5ba3\u5e03\u4e86\u4e24\u7bc7 SCI \u6587\u7ae0\u3002<\/p>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\u3000\u3000\u4e09. \u4ece\u4e34\u5e8a\u7814\u8ba8\u9009\u9898<\/strong><\/p>\n

\u4e34\u5e8a\u7814\u8ba8\u6709\u5f88\u591a\u79cd\uff0c\u5927\u89c4\u6a21\u3001\u968f\u673a\u5bf9\u7167\u7684\u524d\u77bb\u6027\u7814\u8ba8\u662f\u6700\u597d\u7684\uff0c\u4f46\u662f\u4f9d\u636e\u76ee\u524d\u56fd\u9645\u533b\u9662\u7684\u5b9e\u8df5\u60c5\u51b5\u548c\u5c11\u6570\u4e34\u5e8a\u79d1\u5ba4\u7684\u8be6\u7ec6\u72b6\u51b5\uff0c\u5b8c\u6210\u8fd9\u6837\u7684\u7814\u8ba8\u80fd\u591f\u96be\u5ea6\u5f88\u5927;\u800c\u5173\u4e8e\u56de\u5fc6\u6027\u7814\u8ba8\u548c\u65ad\u9762\u7814\u8ba8\uff0c\u6211\u4eec\u8fd8\u662f\u6709\u5341\u5206\u5927\u7684\u52a3\u52bf\u7684\uff0c\u6b21\u8981\u662f\u7531\u4e8e\u6211\u4eec\u7684\u4e34\u5e8a\u60a3\u8005\u591a\u3001\u75c5\u79cd\u5168\uff0c\u53ea\u9700\u80fd\u9759\u4e0b\u5fc3\u6765\u6c47\u603b\u6570\u636e\u3001\u638c\u63e1\u597d\u5982\u4f55\u505a\u7edf\u8ba1\uff0c\u5ba3\u5e03\u4e34\u5e8a\u6587\u7ae0\u5e76\u4e0d\u56f0\u96be\uff0c\u5728\u6b64\u4e3e\u4f8b\u9610\u660e\u3002<\/p>\n

\u4f8b\u4e00\uff0c\u57fa\u5e95\u8282\u591a\u5df4\u80fa\u8f6c\u8fd0\u4f53(DAT)\u663e\u50cf\u5728\u62bd\u52a8\u79fd\u8bed\u7efc\u5408\u5f81\u7684\u7814\u8ba8\u3002\u8fd9\u662f\u6211\u7387\u9886\u7814\u8ba8\u751f\u505c\u6b62\u7684\u9488\u5bf9\u62bd\u52a8\u79fd\u8bed\u7efc\u5408\u5f81\u4e2d\u56fd\u4eba\u7fa4\u7684\u6700\u5927\u6837\u672c\u6570\u768499mTc-TRODAT-1 SPECT\/CT \u524d\u77bb\u6027\u7814\u8ba8\uff0c\u7814\u8ba8\u53d1\u73b0\u57fa\u5e95\u8282\u9ad8\u7a0b\u5ea6\u8868\u8fbe\u7684 DAT \u5728\u521d\u8bca\u672a\u670d\u836f\u7684\u62bd\u52a8\u79fd\u8bed\u7efc\u5408\u5f81\u60a3\u8005\u6700\u7232\u660e\u663e\uff0c\u800c DAT \u4f1a\u968f\u75c5\u7a0b\u7684\u505c\u987f\u800c\u964d\u4f4e\u3001DAT \u548c\u75c5\u7a0b\u5448\u8d1f\u76f8\u5173\uff0c\u7814\u8ba8\u8bc1\u660e DAT \u9ad8\u8868\u8fbe\u4e0e\u6b64\u75c5\u7684\u665a\u671f\u53d1\u75c5\u4eb2\u5bc6\u76f8\u5173\uff0c\u800c\u968f\u75c5\u7a0b\u505c\u987f\u4ee3\u507f\u6027\u6539\u52a8\u4f1a\u4e0b\u8c03\u57fa\u5e95\u8282\u9ad8\u7a0b\u5ea6\u8868\u8fbe\u7684 DAT\u3002\u6587\u7ae0\u6b21\u8981\u8fd0\u7528\u4e86 T \u68c0\u9a8c\u3001\u76f8\u5173\u5256\u6790\u548c\u7ebf\u6027\u56de\u5f52\u5256\u6790\u7684\u7edf\u8ba1\u529e\u6cd5\u3002\u8be5\u7814\u8ba8\u5ba3\u5e03\u4e8e Annuals ofNuclear Medicine\u6742\u5fd7\u3002<\/p>\n

\u4f8b\u4e8c\uff0c\u6b63\u7535\u5b50\u5951\u5408\u7ebf\u8def\u663e\u50cf\u7eb5\u8188\u80bf\u7269\u9776\u672c\u5e95\u6bd4\u503c\u6700\u4f18\u5316\u7684\u56de\u5fc6\u6027\u7814\u8ba8\u3002\u6b63\u7535\u5b50\u5951\u5408\u7ebf\u8def\u7eb5\u8188\u80bf\u7269\u663e\u50cf\u7684\u672c\u5e95\u9009\u62e9\u662f\u4e34\u5e8a\u6838\u533b\u5b66\u9762\u4e34\u7684\u4e00\u4e2a\u96be\u9898\uff0c\u6211\u7387\u9886\u7814\u8ba8\u751f\u5bf9\u4e94\u79cd\u672c\u5e95(\u6c14\u9053\u3001\u8102\u80aa\u3001\u7eb5\u8188\u8f6f\u7ec4\u7ec7\u95f4\u9699\u3001\u5927\u8840\u7ba1\u548c\u5fc3\u810f)\u505c\u6b62\u4e86\u6bd4\u7167\uff0c\u53d1\u73b0\u4e0d\u540c\u672c\u5e95\u7684\u9009\u62e9\u5bf9\u6b63\u7535\u5b50\u5951\u5408\u7ebf\u8def\u663e\u50cf\u7684\u540e\u679c\u5f71\u54cd\u5f88\u5927\uff0c\u800c\u6700\u4f73\u7684\u672c\u5e95\u5e94\u8be5\u662f\u5927\u8840\u7ba1\u3002\u8be5\u7814\u8ba8\u5bf9\u6838\u533b\u5b66\u7eb5\u8188\u80bf\u7269\u663e\u50cf\u826f\u6076\u6027\u5224\u522b\u6709\u91cd\u8981\u7684\u4e34\u5e8a\u4ef7\u503c\u3002\u6587\u7ae0\u6b21\u8981\u8fd0\u7528\u4e86\u65b9\u5dee\u5256\u6790\u548c ROC\u66f2\u7ebf\u5256\u6790\u7684\u7edf\u8ba1\u529e\u6cd5\u3002\u6587\u7ae0\u5ba3\u5e03 \u4e8eNuclear Medicine Communications\u6742\u5fd7\u3002<\/p>\n<\/section>\n<\/section>\n<\/section>\n

\n
\n
\u3000\u3000\u56db. \u4ece\u6839\u5e95\u7814\u8ba8\u9009\u9898<\/strong><\/p>\n

\u6839\u5e95\u7814\u8ba8\u662f\u4e34\u5e8a\u7814\u8ba8\u751f\u6bd4\u62df\u5355\u8584\u7684\u4e00\u73af\uff0c\u6839\u5e95\u7814\u8ba8\u7684\u91cd\u8981\u6027\u662f\u65e0\u987b\u7f6e\u7591\uff0c\u6839\u5e95\u7814\u8ba8\u53ef\u4ee5\u7232\u4e34\u5e8a\u6210\u7ee9\u53d1\u4f5c\u7f18\u7531\u5bfb\u6c42\u5904\u7406\u65b9\u6848\u5e76\u505a\u673a\u7406\u8ba8\u8bba\uff0c\u56e0\u6b64\uff0c\u56fd\u5ea6\u81ea\u7136\u8ff7\u4fe1\u57fa\u91d1\u8d5e\u52a9\u7684\u4e5f\u662f\u6839\u5e95\u7814\u8ba8\u8bfe\u9898\u3002\u5929\u6d25\u533b\u79d1\u5927\u5b66\u603b\u533b\u9662\u6838\u533b\u5b66\u79d1\u4ee5\u6838\u7d20\u533b\u6cbb\u7232\u6b21\u8981\u7684\u6839\u5e95\u7814\u8ba8\u91cd\u70b9\uff0c\u5176\u4e2d\u6211\u5e26\u9886\u7684\u56e2\u961f\u5728\u524d\u4e00\u4e2a\u56fd\u5ea6\u81ea\u7136\u8ff7\u4fe1\u57fa\u91d1\u4e2d\u521d\u6b21\u524d\u77bb\u6027\u5730\u63d0\u51fa\u6076\u6027\u80bf\u7624\u6838\u7d20\u533b\u6cbb\u8010\u836f\u673a\u5236\u7684 NF-\u03baB \u8bf1\u5bfc\u5b9e\u9645\uff0c\u7814\u8ba8\u8bc1\u660e\u7898-131\u4f1a\u62db\u81f4\u5206\u5316\u578b\u7532\u72b6\u817a\u764c\u7ec6\u80deNF-\u03baB \u8868\u8fbe\u6dfb\u52a0\u3001\u529f\u7528\u52a0\u5f3a\uff0c\u7ed3\u5408\u8fd0\u7528 NF-\u03baB \u6291\u5236\u5242\u53ef\u4ee5\u6291\u5236\u8fd9\u79cd\u6539\u52a8\u3002\u7898-131\u7ecf\u8fc7\u6d3b\u5316 NF-\u03baB \u9014\u5f84\u62db\u81f4\u5206\u5316\u578b\u7532\u72b6\u817a\u764c\u7ec6\u80de\u5185\u51cb\u4ea1\u6291\u5236\u56e0\u5b50\u8868\u8fbe\u964d\u4f4e\uff0c\u800c\u7ed3\u5408\u8fd0\u7528 NF-\u03baB \u6291\u5236\u5242\u53ef\u4ee5\u660e\u663e\u6291\u5236\u8fd9\u79cd\u53d8\u5316\uff0c\u7ed3\u5408\u7528\u836f\u5bf9\u7898-131\u62db\u81f4\u5206\u5316\u578b\u7532\u72b6\u817a\u764c\u7ec6\u80de\u7684\u51cb\u4ea1\u53d1\u751f\u4e86\u534f\u540c\u6548\u5e94\u3002<\/p>\n

\u6587\u7ae0\u5ba3\u5e03\u4e8e PLoS ONE \u6742\u5fd7\u3002\u5728\u8fdb\u4e00\u6b65\u7684\u7814\u8ba8\u4e2d\uff0c\u6211\u4eec\u53d1\u73b0 midkine(MK)\u548c NF-\u03baB \u76f8\u4f3c\uff0c\u5747\u5728\u7532\u72b6\u817a\u764c\u4e2d\u8d77\u7740\u91cd\u8981\u7684\u4f5c\u7528\uff0c\u800c MK \u7684\u4f18\u52bf\u662f\u53ef\u4ee5\u5728\u8840\u4e2d\u6d4b\u5b9a\u3002\u6211\u4eec\u7387\u5148\u5c55\u5f00\u4e86\u514d\u75ab\u7ec4\u5316\u6d4b\u5b9a MK \u548c NF-\u03baB \u5bf9\u7532\u72b6\u817a\u4e73\u5934\u72b6\u764c\u4ee5\u53ca\u8f6c\u79fb\u7076\u8bca\u65ad\u4ef7\u503c\u7684\u7814\u8ba8\u3002ROC \u540e\u679c\u663e\u793a\u4e8c\u8005\u5177\u6709\u597d\u7684\u8bca\u65ad PTC \u7684\u624d\u80fd\uff0c\u8bca\u65ad\u7cbe\u786e\u5ea6\u8fa8\u522b\u7232 82.192% \u548c 80.137%;ROC \u540e\u679c\u8fd8\u663e\u793a\u4e8c\u8005\u5177\u6709\u826f\u597d\u7684\u8bca\u65ad PTC \u8f6c\u79fb\u7076\u7684\u624d\u80fd\uff0c\u8bca\u65ad\u7cbe\u786e\u5ea6\u8fa8\u522b\u7232 82.895% \u548c 80.263%\u3002\u8fd9\u4e2a\u6839\u5e95\u7814\u8ba8\u5ba3\u5e03\u4e8e Life Sciences \u6742\u5fd7\u3002\u8fd9\u5c06\u7232\u6211\u4eec\u8bf7\u6c42\u65b0\u7684\u56fd\u5ea6\u81ea\u7136\u8ff7\u4fe1\u57fa\u91d1\u6253\u4e0b\u826f\u597d\u7684\u6839\u5e95\u3002<\/p>\n

\u672c\u6587\u6765\u6e90\uff1aSCI\u541b SCI \uff0c\u7248\u6743\u5f52\u539f\u4f5c\u8005\u6240\u6709\u3002<\/p>\n<\/section>\n<\/section>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

  \u00a0 \u00a0 \u00a0 \u00a0\u53ea\u8981\u786e\u7acb\u4e00\u4e2a\u597d\u7684\u9009\u9898\uff0c\u624d\u6709\u80fd\u591f\u5199\u51fa\u4e00\u7bc7\u597d\u8bba\u6587\u3002\u666e\u901a\u610f\u4e49\u4e0a\uff0c\u9009\u9898\u662f\u6307\u8981\u9009\u62e9\u4e00\u4e2a\u6070\u5f53\u7684\u8bba\u9898\u3001\u63d0\u51fa\u6709\u610f\u4e49\u7684\u8bba\u70b9\uff0c\u5e76\u9009\u62e9\u5408\u9002\u7684\u5199\u4f5c\u65b9\u5f0f\u3002\u76f8\u53cd\uff0c\u8bba\u70b9\u4e0d\u65b0\u6216\u6ca1\u6709\u4ef7\u503c\uff0c\u5373\u4fbf\u8a00\u8bed\u534e\u7f8e\u3001\u8868\u8fbe\u8fdf\u6ede\u3001\u6784\u9020\u6e05\u695a\uff0c\u4e5f\u4e0d … <\/p>\n